Anonymous
Guest
Anonymous
Guest
The fact remains that Provenge is a major cancer breakthrough and recent ASCO presentations suggest it works even better than previously reported AND has active immune cell infiltrating effects on prostate cancer tissues.
The number of Provenge infusion sites is closing in on 1,000 now. The future looks bright despite the anti Provenge campaign waged by the big money interests who represent short sellers, and competing therapies, some of whom post on this board.
The number of Provenge infusion sites is closing in on 1,000 now. The future looks bright despite the anti Provenge campaign waged by the big money interests who represent short sellers, and competing therapies, some of whom post on this board.